EUVIMEDScopri EUVIMED
Übersichtsarbeit

Percutaneous closure of the patent ductus arteriosus: opportunities moving forward

Courtney C Mitchell, Brian K Rivera, Jennifer N Cooper, Charles V Smith, Darren P Berman, Jonathan L Slaughter, Carl H Backes

Congenital Heart Disease · 2019-01 · 14 (1) · 95-99

DOI: 10.1111/chd.12704 ↗

At a glance

Übersichtsarbeit in Congenital Heart Disease, published online on 2019-02-27. Written by Courtney C Mitchell and 6 co-authors. Institution: Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio. Major MEDLINE topics: Infant, Low Birth Weight, Quality Improvement. Cited 23 times so far (Crossref); 32 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

The optimal treatment method for infants with a patent ductus arteriosus (PDA) necessitating closure remains a subject of controversy and debate. While the risks associated with surgical PDA ligation are well described, the available evidence base for alternative management strategies during infancy, including percutaneous closure or conservative (nonintervention) management, are not well explored. Among infants, the goals of this review are to: (a) use rigorous systematic review methodology to assess the quality and quantity of published reports on percutaneous closure vs surgical ligation; (b) compare outcomes of percutaneous closure vs conservative management; and (c) based on recommendations from the International PDA symposium, to elucidate needs and opportunities for future research and interdisciplinary collaboration. The available evidence base, as well as on broad consensus reached at the International PDA Symposium, suggests that a contemporary, pragmatic clinical trial comparing PDA treatment strategies is warranted. Additionally, quality assurance safeguards are necessary in the implementation of newer PDA closure devices. Finally, to determine best approaches to treatment for infants with PDA, tools for consistent data collection and reporting across centers and disciplines are needed to minimize heterogeneity and permit pooled analysis.

Subjects

MeSH terms (MEDLINE)

Infant, Low Birth WeightQuality ImprovementCardiac CatheterizationCardiac Surgical ProceduresDuctus Arteriosus, PatentHumansInfant, Newborn

Author keywords

catheter-based PDA closurepatent ductus arteriosus (PDA)percutaneous ductal closure

Authors and institutions

  • Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio.
  • Center for Surgical Outcomes Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio.
  • Department of Pediatrics, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Center for Integrated Brain Research, Seattle Children's Research Institute, University of Washington School of Medicine, Seattle, Washington.
  • The Heart Center at Nationwide Children's Hospital, Columbus, Ohio.

Cite

APA

Mitchell, C. C., Rivera, B. K., Cooper, J. N., Smith, C. V., Berman, D. P., Slaughter, J. L., & Backes, C. H. (2019). Percutaneous closure of the patent ductus arteriosus: opportunities moving forward. Congenital Heart Disease, 14(1), 95-99. https://doi.org/10.1111/chd.12704

Vancouver

Mitchell CC, Rivera BK, Cooper JN, Smith CV, Berman DP, Slaughter JL, et al. Percutaneous closure of the patent ductus arteriosus: opportunities moving forward. Congenital Heart Disease. 2019;14(1):95-99. doi:10.1111/chd.12704

BibTeX
@article{Mitchell2019,
  author = {Mitchell, Courtney C and Rivera, Brian K and Cooper, Jennifer N and Smith, Charles V and Berman, Darren P and Slaughter, Jonathan L and Backes, Carl H},
  title = {Percutaneous closure of the patent ductus arteriosus: opportunities moving forward},
  journal = {Congenital Heart Disease},
  year = {2019},
  volume = {14},
  number = {1},
  pages = {95--99},
  doi = {10.1111/chd.12704}
}
Start for free →